POWER THE COURSE OF FIGHTING DISEASES AND SAVING LIVES
Domain expertise, global resource, long-term capital
PORTFOLIO NEWS
November 14, 2018San Francisco, November 13th, 2018 – Tempest Therapeutics Inc. presented a poster at the Society...November 13, 2018BELTSVILLE, Md. – November 13, 2018 – NextCure Inc., a privately-held biopharmaceutical company...November 12, 2018South San Francisco, CA – November 11, 2018 – Harpoon Therapeutics, Inc. (“Harpoon”), a clinical...November 6, 2018INDIANAPOLIS, IN, and BELTSVILLE, MD — Eli Lilly and Company (NYSE: LLY) and NextCure, Inc. today...October 30, 2018Terns Pharmaceuticals Completes $80 Million Series B Financing to Advance Pipeline of Drugs to...October 24, 2018BELTSVILLE, Md.--(BUSINESS WIRE)--NextCure, Inc., a privately-held biopharmaceutical company...October 19, 2018Dr. Athena Countouriotis Promoted to Chief Executive Officer and Member of the Board of...October 18, 2018SAN DIEGO and SHANGHAI, Oct. 18, 2018 /PRNewswire/ -- In collaboration with Fudan University...October 18, 2018SAN DIEGO and SHANGHAI, Oct. 18, 2018 /PRNewswire/ -- Fudan University's Taizhou Health Science...October 2, 2018FierceBiotech has revealed 2018 Fierce 15 biotechnology companies. The fifteen winners are...More Posts
Company
Shanghai
Room2909-14, 168 Hubin Road, Huangpu District, Shanghai, China.
Hong Kong
Unit 1109, Two Chinachem Central, 26 Des Voeux Road Central, Hong Kong
US
2730 Sand Hill Road, Suite 130, Menlo Park, CA
copyright © 2018 Lilly Asia Ventures all rights reserved.
All Posts
×